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Circadian ( 24 hour) timing systems pervade all kingdoms of life, and temporally optimize behaviour and
physiology in humans. Relatively recent changes to our environments, such as the introduction of artificial
lighting, can disorganize the circadian system, from the level of the molecular clocks that regulate the timing
of cellular activities to the level of synchronization between our daily cycles of behaviour and the solar day.
Sleep/wake cycles are intertwined with the circadian system, and global trends indicate that these too are
increasingly subject to disruption. A large proportion of the world’s population is at increased risk of environ-
mentally-driven circadian rhythm and sleep disruption, and a minority of individuals are also genetically pre-
disposed to circadianmisalignment and sleep disorders. The consequences of disruption to the circadian system
and sleep are profound and include myriad metabolic ramifications, some of which may be compounded by
adverse effects on dietary choices. If not addressed, the deleterious effects of such disruption will continue to
cause widespread health problems; therefore, implementation of the numerous behavioural and pharmaceu-
tical interventions that can help restore circadian system alignment and enhance sleep will be important.
I. Introduction
MANKIND’S HISTORIC FASCINATION with thetemporal world has taken many forms, from pil-
grimages to Stonehenge at the time of the summer solstice
for over 5000 years to fanciful notions about time travel.
This world has shaped life by means of such rhythmic
environmental stimuli as the 24 hour light/dark (LD) cy-
cle, stimuli that have made organisms evolve their own
timing systems to anticipate and adapt to daily and sea-
sonal cycles. Thomas Edison’s seminal invention of the
electric light bulb in 1879 brought unprecedented possi-
bilities, and the American inventor is attributed with once
remarking “Thedoctor of the futurewill give nomedicine,
butwill instruct his patient in the care of the human frame,
in diet, and in the cause and prevention of disease”. Little
was he aware that mistimed use of his great gift to the
world is now one of several human-imposed environmen-
tal changes that predispose us to many diseases by way of
circadian rhythm and sleep disruption. The purposes of
this review are to detail our current knowledge about the
causes and metabolic consequences of such disruption,
and to highlight strategies to counteract these conse-
quences. Although studies of other animals have been piv-
otal in furthering our understanding of the regulation of
the circadian system and sleep, it may be premature to
extrapolate findings from commonly studied model or-
ganisms, particularly nocturnal ones, to our own, diurnal
species.Therefore, this review focusesonhumanstudiesof
healthy participants where possible, beginning with ob-
servational studies that provide insights into the preva-
lence of circadian rhythm and sleep disruption.
Table 1 provides an overview of sources and mecha-
nisms of circadian rhythmdisruption, one source ofwhich
is shift work. As shift workers oftenwork during the night
(the rest phase for humans, as diurnal organisms), they are
at particular risk of circadian rhythm and sleep disruption
(6–9). Shift workers are also predisposed to other health
disorders, such as gastrointestinal (GI) issues (10), and
shift work exposure is related to risk of some diseases in a
dose-response fashion, including breast cancer and met-
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abolic syndrome (11, 12). Findings from observational
studies also suggest that circadian rhythm and sleep dis-
ruption is intertwined with some of these disorders: Com-
pared to day shift workers matched for body mass index
(BMI), for example, some of the adverse metabolic con-
sequences experienced by night shift workers are coinci-
dent with sleep disturbances (13). As shift workers make
up 17% of the European workforce and 15% of the
US workforce (14, 15), the societal implications of the
health consequences of shift work are substantial.
Like shift work, jetlag induces circadian rhythm and
sleep disruption. Although the health consequences of fre-
quent jetlag are equivocal (16), any deleterious effects of
jetlag-induced circadian rhythm and sleep disruption will
become more widespread, as it has been estimated that
there will be  831 million more air-bound passengers
globally in 2016 compared to 2011 (17).
Whereas shiftwork and jetlag entail overt disruption to
the circadian system and sleep, even ‘normal’ working
hours can result in more subtle circadian systemmisalign-
ment and sleep restriction, particularly among evening
chronotypes. This is because many individuals use alarms
to produce wakefulness when sleep would otherwise oc-
cur. Hence, bed times tend to differ between work days
and nonwork days, and a discrepancy of at least one hour
between midsleep time on work days and nonwork days
affects 87%ofNorthern Europeans. This phenomenon
is often termed “social jetlag” and is associated with obe-
sity and behavioral ramifications, such as increased alco-
hol consumption and smoking (18, 19). Similarly, greater
intra-individual sleep timing variability has been linked to
higher fat mass and lower lean mass (20), as well as car-
diometabolic disease risk factors like insulin resistance
(21, 22).
Alarm clock use contributes to pervasive short sleep
duration among adults, and analysis of  250 000 self-
reports of sleepworldwide suggests that sleep duration on
workdays has declined by  3.7 minutes per year in the
last decade (18), the significance of which is that sleep
duration is associated with numerous chronic diseases.
For example, sleep duration has a U-shaped association
with type two diabetes mellitus (T2DM) prevalence. The
mechanisms underlying the association between short
sleep and increased T2DM risk will be discussed subse-
quently; why long sleep is associated with increased
T2DM risk is more contentious, but low socioeconomic
status, depression and other comorbidities are thought to
contribute to this relationship (23).
An inverse association between sleep duration and ad-
iposity is evident in observational studies (24, 25). In ad-
dition, findings from a recent meta-analysis indicate that
a negative association between sleep duration and waist
circumference is apparent (26). Importantly, fat mass dis-
tribution is particularly salient to metabolic health, with
central obesity linked to increased risk of several diseases.
The relationship between sleep duration and adiposity is
not limited to adults. As chronotype delays during growth
and is latest on reaching physicalmaturity, enforcing early
school starts disrupts sleep timing and duration during
adolescence, a critical developmental period (27) and,
Table 1. Sources and Primary Mechanisms of Circadian Rhythm Disruption
Mechanism
Environmental Behavioural Biological
Light/dark
cycle
disruption
Feeding/fasting
cycle
disruption
Rest/activity
cycle
disruption
Genetic
disruption
(e.g.
clock
gene
mutations)
Physiological
disruption
(e.g. retinal
dysfunction)
Source
Work schedules (e.g. shift
work, social jetlag, early
school start times)
    
Jetlag     
Unusual photoperiods (e.g.
Polar regions)
    
Circadian rhythm sleep-wake
disorders (e.g. non-24-hour
sleep-wake disorder)
    
Senescence     
Disease states (e.g.
Alzheimer’s, Smith-Magenis
syndrome)
    
2 Circadian Rhythm and Sleep Disruption Endocrine Reviews
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 04 November 2016. at 03:50 For personal use only. No other uses without permission. . All rights reserved.
once more, short sleep during this period is prospectively
associated with obesity development (28). Relationships
between sleep and adiposity are related to eating behav-
iors, and links between circadian rhythm and sleep dis-
ruption, dietary habits and fat mass are further apparent
in less common disorders like night eating syndrome (29).
In contrast to effects of jetlag andworking demands on
the circadian system and sleep, some individuals are at
increased risk of circadian rhythm and sleep disruption
regardless of cultural changes. At times this is environ-
mentally-driven. All 24 time zones converge at the Poles,
for example, where low amplitude LD cycles and extreme
temperatures are associated with health ramifications
(30). In other instances, underlying pathologies are at
fault. This is true in the case of circadian rhythm disrup-
tion in blind individuals without light perception (31),
mostofwhomexperiencenon-24hour sleep-wake rhythm
disorder in which sleep quality is highly variable. Sleep
quality also deteriorates with advancing age, as do other
circadian rhythms (32); thus, more of our ageing popula-
tion is likely to experience circadian rhythm disruption.
Furthermore, with senescence comes a predisposition to
various diseases also characterized by circadian system
disorganisation, one of which is Alzheimer’s disease (33).
Together, it appears that the pervasiveness of circadian
rhythm and sleep disruption is rising, and observational
evidence implicates this disruption in adverse health ef-
fects. Our understanding of the mechanisms underlying
these consequencesprovides the foundation fromwhich to
intervene appropriately, and disorganisation of the circa-
dian system is at the center of many of these health
problems.
II. The circadian system
A. The suprachiasmatic nuclei
The two suprachiasmatic nuclei (SCN) of the anterior
hypothalamus primarily coordinate the oscillator systems
that temporally regulate physiology and behavior (Figure
1). The preeminent roles of the SCN in locomotor, hor-
monal and feeding circadian rhythms were demonstrated
by early ablation studies (34–36). SCN transplantation
Table 2. Glossary
Chronobiotic
An agent capable of modifying a biological rhythm’s amplitude (the difference between a rhythm’s
acrophase [peak] or bathyphase [trough] and its mean value), period (the time after which a phase of
the rhythm oscillation recurs) or phase (the instantaneous state of an oscillation within a period).
Chronotype An individual’s phase angle of entrainment (for example, the timing of core body temperature nadir relative to
dawn).
Circadian
rhythm
An endogenous rhythm with a period of  24 h that is entrainable, persists in the absence of external time cues (1)
and is temperature compensated: For most biological systems, the Q10 temperature coefficient-a measure of the
rate of change of a biological or chemical system after increasing the temperature by 10 C-is  2; for the circadian
system, however, it is close to 1, allowing stable circadian rhythms in different thermal environments (2). Circadian
time (CT) is synonymous with internal time and is the time of one full circadian period. CT 0 is commonly subjective
dawn.
Circadian
rhythm
disruption
Disruption of biological timing. This can occur from the level of the molecular clock (that temporally regulates cellular
activities) to misalignment between behavioural and environmental cycles. Circadian rhythm disruption produces a
loss of characteristic phase relationships in oscillatory subsystems, the nature of which is ill-defined.
Constant
routine
Constant routine experimental protocols attempt to enforce unchanging behavioural and environmental conditions,
such as constant dim lighting, evenly-spaced isoenergetic snack consumption, semi-recumbent posture, and
wakefulness, to distinguish true endogenous circadian rhythms from diurnal rhythms arising from both
endogenous and exogenous factors.
Entrainment Coupling of an endogenous rhythm to a zeitgeber, such that the oscillations have the same frequency
(synchronization) or frequencies that are integral multiples (frequency demultiplication) (3). Entrainment is achieved
when internal period () matches external period (T). As the mean free-running human  is  24.2 h (4,5), circadian
rhythms must be entrained to the 24 h LD cycle daily. A short or long free-running  typically entrains earlier or
later, respectively.
Forced
desynchrony
Forced desynchrony experimental protocols use LD cycles outside the range of entrainment to distribute sleep and
wakefulness across the circadian cycle and hence uncouple effects of behavioural cycles from effects of circadian
rhythms. An example protocol might involve 28 h sleep/wake cycles, three cycles of which would produce  180°
misalignment between the circadian clock and LD cycle.
Peripheral
clocks
Peripheral clocks comprise extra-SCN brain clocks and clocks in peripheral tissues. These clocks produce circadian
rhythms in local tissue processes.
Sleep disruption By sleep disruption, we refer to externally-mediated changes in sleep continuity, timing or duration (restriction entails
reduced sleep duration, whereas deprivation is the absence of sleep).
Zeitgeber The oscillation force that entrains a biological rhythm (3). The 24 h LD cycle is the primary zeitgeber for humans. High
amplitude, relatively consistently timed zeitgebers help ensure stable entrainment (for example, high light exposure
during the day and minimal light exposure at night). Zeitgeber time (ZT) is the duration of one zeitgeber cycle. ZT 0
is commonly dawn or the beginning of the warm phase.
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into SCN-ablated hamsters confirmed their control of cir-
cadian rhythm period (37) and, by encasing the SCN in
semipermeable membranes that prevented synaptogen-
esis, the SCN were shown to produce diffusible signals
sufficient to restore circadian activity rhythms (38). Sev-
eral of these SCN secretions have since been identified
(39–41).
The foremost zeitgeber that entrains the SCN to the 24
hour day is the LD cycle and, together with rod and cone
photoreceptor cells, melanopsin-containing intrinsically
photosensitive retinal ganglion cells in the inner retinae
relay photic information to the SCN via a monosynaptic
pathway to permit synchronization (43). In response to
photic stimuli, a multisynaptic pathway from the SCN to
adrenergic fibers innervating the pineal gland regulates
norepinephrine release from these fibers and hence mela-
tonin synthesis (44, 45). Melatonin conveys photoperi-
odic information to the pituitary pars tuberalis, a key
nexus in the regulation of seasonal rhythms in physiology
in photoperiodicmammals, which undergo seasonal body
mass and reproductive changes (46, 47). Although the
human melatonin rhythm is also sensitive to photoperiod
changes (48), the presence of artificial lighting suppresses
seasonal changes in circadian rhythms (such asmelatonin)
thatmight otherwise be evident (49).As the SCNalsohave
the melatonin receptors MT1 and MT2 (50, 51)
Figure 1.
Temporal control of physiology. Light exposure provides the primary time cue for the central clock in the suprachiasmatic nuclei (SCN) of the
hypothalamus and suppresses melatonin synthesis by the pineal gland. Artificial light exposure at night can therefore disrupt the SCN clock and
melatonin rhythm. As a diurnal species, melatonin is hypnogenic in humans, although a recent prospective study of pinealectomy demonstrated
that endogenous melatonin may not have a strong regulatory role in sleep (42). The sleep/wake cycle has been effectively simulated by a two-
process model in which a circadian process (C) influences wakefulness and interacts with a sleep-promoting process (S) that accumulates during
wakefulness. Within the hypothalamus-a nodal point of body temperature regulation-the SCN influences the circadian rhythm of body
temperature, a key synchronizer of clocks in peripheral tissues. Use of thermostats can obviate daily oscillations in temperature, which could
perhaps influence some circadian rhythms. In addition to temperature mechanisms, the SCN influences clocks in peripheral tissues through neural
signals communicated via the autonomic nervous system (ANS), as well as the timely secretion of signaling factors such as prokineticin 2.
Hypothalamic-pituitary-peripheral organ axes are important to hormonal regulation of the circadian system. For example, corticotropin releasing
hormone enters the portal system through the median eminence (ME) of the hypothalamus and stimulates the secretion of adrenocorticotropic
(ACTH) hormone by the anterior pituitary gland. ACTH then regulates adrenal cortex production of cortisol, a hormone with a robust circadian
oscillation and important synchronizing effects in many peripheral clocks. The timing of metabolic processes in peripheral clocks is also modified by
nutritional status, and peripheral clocks relay metabolic information back to the hypothalamus through the ME. Today, around-the-clock access to
food can distort the clear feeding/fasting cycles that typified much of our history.
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(MTNR1A and MTNR1B in humans, respectively), mel-
atonin feeds back to the master clock.
The circadian system has central roles in sleep/wake
cycle regulation, as seen by the gating of sleep at specific
circadian phases; furthermore, the circadian phase at
which sleep occurs influences sleep duration, continuity
and architecture (52). In 1982 Borbély proposed a two-
process model of sleep regulation in which a circadian
process also interacts with a homeostatic process to reg-
ulate sleep (53). The circadian process influences alertness
and the sleep process is hypnogenic, rising during wake-
fulness and falling during sleep, in a manner akin to an
hourglass timer. Borbély’s model has proven effective in
simulating sleep in myriad experimental conditions (54),
but many of the mechanisms by which the circadian sys-
tem and sleep/wake states interact remain elusive.
B. Clock genes
Immediate early genes in the SCN respond to light ex-
posure, including clock genes (55), the genes that gener-
ate  24 hour gene transcription rhythms. These same
clock genes exist in cells throughout bodily tissues and
form delayed, interlocking gene transcription/translation
negative feedback loops.Thepositive armof the core clock
loop comprises the basic helix-loop-helix transcription
factors circadian locomotor output cycles kaput
(CLOCK) and brain and muscle aryl hydrocarbon recep-
tor nuclear translocator-like 1 (BMAL1). In tissues such as
the vasculature, CLOCK’s functions are replaced by its
paralogue neuronal period-aryl hydrocarbon receptor nu-
clear translocator single-minded protein 2 (NPAS2). Con-
trary to prior findings, it was recently shown that loss of
CLOCK does not produce arrhythmicity in peripheral
cells; rather, it appears that these cells only become ar-
rhythmic whenNpas2 is knocked down in the presence of
CLOCKdeficiency (56), indicating amore prominent role
ofNPAS2 in themolecular clock than previously thought.
CLOCK and BMAL1 heterodimerize to activate tran-
scription of clock-controlled genes (CCGs). CCGs include
the negative limb of the clock, namely cryptochrome
(CRY) 1–2 and period (PER) 1–3 proteins. These then
accumulate in the cytosol, multimerize, translocate into
the nucleus, repress CLOCK-BMAL1 transactivating
function, and terminate CRY1–2 and PER1–3 transcrip-
tion. PER-CRY complexes are then degraded by casein
kinase 1 (CK1) , CK1 and F-box/LRR-repeat protein 3.
CLOCK-BMAL1 inhibition ends, thus closing the nega-
tive feedback loop. At least five auxiliary feedback loops
add robustness and couple the molecular clock to meta-
bolic status (57). Antiphasic to the core loop, the best
characterized of these modulates BMAL1 transcription:
RAR-related orphan receptor  activates BMAL1 tran-
scription, andReverse-erythroblastosis (REV–ERB) and
REV–ERB repress BMAL1 transcription.
The rhythmic transcription of clock genes persists even
in cultured fibroblast cells (58) and, as fibroblast gene
expression periods may be consistent with whole body
circadian rhythm periods (59), clock genes may be key
determinants of circadian period and hence chronotype
and sleepphenotypes.This is supportedby recent genome-
wide association (GWA) studies that have linked genetic
loci near established components of the molecular clock
with chronotype (60, 61). Nevertheless, not all studies
have found that in vitro fibroblast period duration is cor-
related with in vivo period (62). In adulthood, circadian
period advances with increasing age, but a difference in in
vitro fibroblast period has not always been found between
young and elderly individuals. In the presence of sera from
the elderly participants, however, fibroblast period was
reduced in comparison to treatment with sera from the
young adults, suggesting that circulating factors are also
determinants of oscillator periods and perhaps chrono-
type (63). Interestingly, although sleep timing advances
with age in adulthood, changes in body temperature
rhythm periods are not so clear (64, 65). As the body
temperature rhythm is partly regulated by the SCN, it is
plausible that humoral factors influence circadian oscil-
lations in some peripheral cells but not the SCN, although
this hypothesis requires testing.
Clock genes regulate the transcription of CCGs, hun-
dreds of which control the timing of tissue-specific func-
tions (66). An aggregation of mouse studies has shown
that  50% of protein-coding genes have 24 hour gene
expression profiles in at least one set of conditions (67).
While some genes may be rhythmic in multiple tissues,
their phases often differ between and even within tissues,
and rhythmic gene expression is largelyorgan-specific (68,
69). Our understanding of the range of healthy phase re-
lationships between these systems is poorly characterized,
however.
Target genes of circadian clock genes are enriched for
metabolic pathways, and metabolic genes that are direct
targets of CLOCK-BMAL1 heterodimer also feedback to
molecular clock components. These metabolic genes in-
clude D-box binding PAR bZIP transcription factor, dif-
ferentiated embryo-chondrocyte expressed genes 1 and 2,
estrogen-related receptor , nicotinamide phosphoribo-
syltransferase, peroxisomeproliferator-activated receptor
, and proper homeobox 1 (57).
It is important to note that as the metabolic state of the
cell is coupled to the molecular clock (70), the pervasive-
ness of rhythmic cellular activities is modified by factors
such as diet. The circadian system reciprocally interacts
with feeding/fasting cycles via coupling between the mo-
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lecular clock andmetabolic regulators. In the postabsorp-
tive state, decreased energy availability increases 5AMP-
activated protein kinase (AMPK) phosphorylation to
enhance ATP formation; in the postprandial state, in-
creased energy availability stimulates anabolic cellular
processes via mechanistic target of rapamycin signaling.
This pathway is coupled to the molecular clock by phos-
phorylation of glycogen synthase kinase 3, which in turn
regulatesPERstability andhenceperiod length (71).Using
AMPK to further exemplify how energy sensors impinge
on the molecular clock, AMPK interacts with the
NAD()-dependent protein deacetylase SIRTUIN (SIRT)
1, which subsequently deacetylates and degrades period 2
to ensure high amplitude daily transcription profiles of
several clock genes (72). Furthermore, SIRT1 and SIRT6
have particularly pivotal roles in the temporal control of
metabolism by controlling chromatin modifications and
hence the rhythmic transcriptionof distinct sets of genes in
the liver, with SIRT1 primarily regulating genes involved
in peptide and cofactor metabolism, and SIRT6 influenc-
ing genes integral to carbohydrate and lipid metabolism
(73).
Finally, although there is contention regardingwhether
humans are seasonally photoperiodic (74), daily gene ex-
pression rhythms occur within the context of seasonal
changes in expression of protein-coding genes. Seasonal
gene expression changes have been shown in independent
populations and are linked to changes in the cellular com-
position of blood. Seasonal gene expression fluctuations
may underlie changes in immune function, and seasonal
variations in expression profiles ofmetabolic genes in adi-
pocytes are also apparent (75). As the incidences of some
cardiometabolic diseases oscillate seasonally (76, 77),
these findings may have implications for understanding
and treating such pathologies; however, seasonal changes
in disease riskmay also be related tomyriad other factors,
including changes in health behaviors and environmental
temperature.
C. Post-transcriptional clock regulation
Within a species, similar proportions of the transcrip-
tome, proteome and metabolome oscillate with 24 hour
profiles (78–80). Although there are mostly minimal de-
lays between gene transcription and translation, it has
been shown using a human cell model that some arrhyth-
mic gene transcripts produce rhythmic products via daily
translation profiles (81). Delays between gene transcrip-
tion and translation vary across the day, partly due to
RNA-binding proteins which modify processes such as
pre-mRNAsplicing, polyadenylation andRNAdecay (82,
83). Post-translational clock protein modifications in-
clude acetylation, O-GlcNAcylation, poly adenosine
diphosphate (ADP) ribosylation, phosphorylation, SU-
MOylation, and ubiquitination (84–89). ncRNA expres-
sion also fluctuates in similar proportions to protein-cod-
ing gene transcripts, conferring another level of post-
transcriptional regulation, and therefore ncRNAs likely
influence molecular clock regulation (78). Collectively,
such post-transcriptional processes contribute to appro-
priate, tissue-specific responses of peripheral clocks.
D. Nontranscriptional oscillators
Nontranscriptional oscillations in peroxiredoxins, re-
dox-sensitive antioxidant proteins involved in electron
transfer, respond to oxidation in cells such as erythrocytes
(90). These oscillations persist in the absence of zeitgebers,
and are temperature-compensated and entrainable. They
are sustained in the absence of clock gene expression feed-
back loops and are the most highly conserved clocks
known (91, 92). Their integration with the circadian sys-
tem, sleep homeostasis and metabolic networks is little
understood, however.
E. Internal synchrony
Clock gene expression rhythms have divergent periods
that do not resonate without synchronizing agents (93).
Disruption of the SCNclock dampens anddesynchronizes
peripheral tissue circadian rhythms (94), and uncoupling
of appropriate phase relationships between endogenous
rhythms-internal desynchronization-is hypothesized to
contribute to the deleteriousmetabolic effects of circadian
rhythm disruption. The SCN synchronize circadian
rhythms by autonomic, behavioral, humoral, and temper-
ature mechanisms. The former comprise caudal efferents
to the subparaventricular zone and dorsomedial nucleus,
dorsal efferents to themidline thalamic nuclei, and rostral
efferents to the anterior hypothalamus and preoptic area
(95). The paraventricular nucleus is particularly impor-
tant in the regulation of circadian rhythms in activity, au-
tonomic processes, and secretion of hormones including
melatonin and cortisol (96).
Multisynaptic efferents from the SCN to the periphery
help regulate the availability of nutrients like glucose in the
blood (97), as well as hormone secretion rhythms by or-
gans including the adrenal glands, adipose tissues, pan-
creas, and thyroid gland (98–101). In turn, humoral fac-
tors from the periphery relay information back to
hypothalamic regions via the hypothalamic median emi-
nence (102).
Some clock genes are directly regulated by glucocorti-
coids via glucocorticoid response elements (103). SCN le-
sions nullify liver gene transcription rhythms, but gluco-
corticoid receptor activation restores  60% of these
rhythms, demonstrating an important synchronizing role
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for cortisol in some peripheral clocks (104). The strength
of effects of glucocorticoids on peripheral clock rhythms
differs between tissues; the kidneys and lungs, for exam-
ple, are yet more responsive to glucocorticoids than the
liver, which is more entrained by feeding (105).
As homeothermic vertebrates, humans are resistant to
temperature entrainment by the environment, and exper-
iments in mice tissues have shown that the SCN are re-
sponsible for this resistance (106). Although thermoreg-
ulation is regulated by the interaction of many structures
located primarily in the hypothalamus, brainstem and spi-
nal cord, the SCN are integral to the core body tempera-
ture rhythm, a rhythm that has important synchronising
effects on oscillators throughout the body (106). Further-
more, a specific component of the molecular clock has
been identified as a key nexus between the circadian and
thermoregulatory systems, as deletion ofRev-erb inmice
abolishes the core body temperature rhythm by changing
brown adipose tissue activity (107).
F. Temporal partitioning of physiology
Internal synchrony temporally partitions physiology to
aid physical activity and energy harvesting during the bi-
ological day (active phase), inactivity and energy mobili-
zation during the rest phase, and time-of-day appropriate
changes in immune function (108, 109). Clock-regulated
changes inbloodpressure (BP), heart rate, and skeletal and
heartmuscle contractile efficiencyand substrateoxidation
ready thebody forphysical activity (110–112).Asa result,
the circadian system ensures peak physical performance
during the active phase.
Historically, physical activity has been necessary to
procure food, andduring theactivephase rhythms in in the
GI system support timely digestion. Gastric emptying and
colonic motility, for example, are slowest in the evening,
and the transit of indigestible food from the stomach to the
small intestine is powered by the migrating motor com-
plex, the speed of which is more than twice as high during
the day as at night (113–115). Rhythmic bile acid produc-
tion is central to cholesterolmetabolismandabsorptionof
nutrients including fat-soluble vitamins, and Kruppel-like
factor 15 and fibroblast growth factor 15 have pivotal
roles in this regulation (116). Rhythmic changes in the
activity of some intestinal nutrient transport proteins
(117) and temporal control of enzyme activity is also im-
portant to metabolism. Using lipids to exemplify this, re-
duced postprandial lipoprotein lipase activity apparently
contributes to impaired lipid tolerance in the evening
(118). It should be noted that it is unclear whether the
aforementioned GI rhythms are partly clock-regulated or
exclusively artifacts of behavioral cycles. Other enzymes
involved in hepatic lipid metabolism are known targets of
the molecular clock and shape rhythms in processes like
lipid accumulation (119). Nocturnin, for example, is
clock-controlled and regulates triacylglycerol synthesis
and storage, aswell as chylomicron formation in intestinal
enterocytes (120).
Gut microbiota composition changes with feeding and
fulfils time of day-specific functions in humans and mice,
with energy metabolism roles during the active phase and
detoxification processes during the rest phase (121). Rec-
iprocity between the circadian system and microbiota is
evident, as Bmal1 deletion nullifies these oscillations
(122). Furthermore, clock gene expression is altered in
germ-free mice, and these mice do not gain body mass
compared to conventionally-raised mice, perhaps due to
differences in microbe-derived metabolites like short-
chain fatty acids (123).
Whereas it is unclear whether rhythmic secretion of
several GI hormones is shaped by the circadian system
(such as gastric inhibitory polypeptide, gastrin and gluca-
gon-like peptide-1 (124, 125)), other hormones are de-
monstrably clock-regulated. Constant routine and forced
desynchronyexperimentshave shown thatplasmaglucose
and triacylglycerol have clear circadian rhythms, with an
acrophase in the biological night (126–128), indicating
circadian system regulation of energy substrate metabo-
lism. This is likely related to circadian rhythms in impor-
tant hormones in energy metabolism, such as insulin. In-
sulinemia, like insulin sensitivity, peaks in the daytime in
humans to promote efficient energy storage (128), and an
acrophase in the insulin-sensitizing adipokine adiponectin
in the middle of the active phase supports this process
(129).
Rhythmic growth hormone (GH) secretion is another
important determinant of daily changes in substrate oxi-
dation.Althoughaminor influenceof the circadian system
has sometimes been detected, sleep has a dominant influ-
ence on GH secretion (5). Growth hormone has an acro-
phase near the onset of slow wave sleep (SWS), and GH
profiles are further characterized by episodic surges a few
hours after meals (130, 131). Its rhythm differs a little
between the sexes (132). Together with insulin and insu-
lin-like growth factor-1, GH aids nitrogen retention dur-
ing high energy availability; during reduced energy avail-
ability, as occurs during sleep,GH stimulates lipolysis and
ketogenesis (133), inducing insulin resistance and thereby
sparing glucose and protein oxidation (134).
Like GH, prolactin is primarily synthesized and se-
cretedby the anterior pituitary and fulfils300biological
actions, including roles in homeostasis, lactation and re-
production (135). Prolactin also influences appetite in a
species-specific way, and chronic hyperprolactinemia is
associated with increased body mass in humans. Further-
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more, prolactin has roles in lipid metabolism, largely re-
ducing lipid storage in adipocytes, and also affects glucose
metabolism by stimulating insulin secretion (136). A cir-
cadian rhythm in prolactin is evident in constant routine
protocols, of larger amplitude in women and with an ac-
rophase in the rest phase (137). Subcutaneous prolactin
injections prolong rapid eye movement (REM) sleep in
rats (138), and prolactin is also associated with SWS in
humans (139).
Melatonin synthesis occurs during darkness and in-
creases sleep propensity in humans, which may be related
to melatonin’s hypothermic effects (140). Melatonin may
have important roles in metabolic regulation, perhaps
helping prevent nocturnal hypoglycemia by inhibiting in-
sulin secretion (141). As this was demonstrated in mice,
however, different responses may be apparent in humans.
Interestingly, the MTNR1B T2DM risk variant
rs10830963 (142–144) has been linked to prolongedmel-
atonin synthesis duration and delayed melatonin offset
phase in humans. As melatonin inhibits glucose-stimu-
lated insulin secretion ex vivo, it is plausible that extended
melatonin synthesis into waking could contribute to
T2DM risk, particularly among carriers with early sleep
times (145). As melatonin also exerts receptor-indepen-
dent effects in free radical scavenging (146), melatonin
perhaps also contributes to temporal regulation of im-
mune function, although further research is required.
Finally, an acrophase in leptin secretion during the rest
phase may contribute to reduced appetite for most food-
stuffs in the biological morning in humans, permitting
consolidated sleep despite declining energy availability
(147). This hypothesis is not supported by the finding that
nocturnal rats also have an acrophase in leptin secretion
during darkness (their active phase) (148), although it is
possible that leptin has different roles in diurnal and noc-
turnal species.
III. Consequences of circadian rhythm and sleep
disruption
A. Sleep restriction and sleep deprivation
1. Metabolic consequences
Sleep restriction is ubiquitous and its metabolic conse-
quences are profound. One of the best characterized met-
abolic sequelae of sleep disruption is disrupted glucose
metabolism. This was first shown in 1999 in a study in
whichparticipants experienceda24%reduction in insulin
sensitivity after 5 nights of sleep restriction to 4 hours per
night. Altered 24 hour endocrine profiles were also evi-
dent, as thyrotropin secretionwas impaired andnocturnal
cortisol secretion increased (149). This finding of abnor-
mal glucose metabolism has been consistently replicated,
and much progress has been made in understanding the
contributing mechanisms (Figure 2).
In thepostprandial state, thebrain accounts for roughly
half ofwhole body glucose disposal, and sleep deprivation
reduces this use (150). Cephalic phase neurogenic signals
from the brain anticipate food consumption and stimulate
the insulin secretion. Insulin resistance following sleep re-
striction is not associated with altered cephalic phase in-
sulin secretion (151), but rather appears to result primarily
from insulin resistanceoutside the liver (152), and changes
in adipose tissue insulin signaling may be particularly im-
portant (153). Given the roles of the molecular clock in
glucose and lipid metabolism, reduced glucose tolerance
and metabolic dysregulation after sleep disruption may
also be related to epigenetic and transcriptional changes in
themolecular clock in peripheral tissues important to glu-
cose disposal, including adipose tissue and skeletal mus-
cle. Indeed, there is increased DNA methylation of the
promoter region of CRY1 and two regions near period
PER1 in adipocytes, aswell as reducedBMAL1andCRY1
transcription in myocytes after sleep deprivation (154).
Consistent with Randle’s glucose fatty-acid cycle (155),
increased release of nonesterified fatty acids from adi-
pocytes after sleep restriction likely also contributes to
insulin resistance (156). Further mechanisms reducing in-
sulin sensitivity after sleep disruption include stimulation
of gluconeogenesis via increased sympathetic activity of
the autonomic nervous system (157), and a shift in cyto-
kine balance towards a more inflammatory state (158).
Related to this, sleep curtailment affects numerous aspects
of immune function. For example, one week of sleep re-
striction inmen increased circulatingwhite blood cells and
changed their diurnal rhythm.Notably, altered cell counts
had not returned to baseline after 9 days of recovery sleep
(159). Suchchanges in immune functionmaycontribute to
the development of diseases associated with immune sys-
tem changes, such as T2DM (160).
It has alsobeen shown that changes in sleeparchitecture
during sleep disruption contribute to changes in glucose
metabolism. Indeed, restricting sleep to the first half of the
night produces distinct endocrine effects to restriction to
the second half (161), and different sleep stages produce
distinct physiological changes: Selective SWS restriction,
for example, reduces insulin sensitivity in a dose-response
manner in adults, independent of sleep duration, although
adolescentsmaybemore resistant to this effect (162, 163).
Many individuals, especially late chronotypes, use
alarmclocks to artificially curtail sleepduring theworking
week, and simulating this behavior by enforcing five days
of restriction to five hours of sleep with early waking dur-
ing the rest phase reduced intravenous (IV) and oral in-
sulin sensitivity by  20% in healthy adults (164). Intra-
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venous insulin sensitivitywas not restored by three days of
recovery sleep; notably, three days is longer than most
working adults have to catch up on sleep each week. A
limitation of most experimental sleep restriction studies is
that they often enforce large changes in sleep duration, but
restriction by 90 minutes nightly-an amount similar to
that experienced by many (18)-has also been shown to
reduce insulin sensitivity after one week in young men
(165). In this healthy population, impaired insulin sensi-
tivity dissipated with continued exposure to such
restriction.
A detailed review of obstructive sleep apnea (OSA) is
beyond the scope of this review. However, as studies have
consistently shown that OSA is associated with impaired
insulin and glucose metabolism, its features are briefly
outlined. OSA is a disorder in which individuals experi-
ence episodic upper airway closure and hence intermittent
hypoxia during sleep. OSA is further characterized by re-
duced sleep duration, sleep fragmentation, reduced SWS,
and increased sympathetic nervous system activity and
oxidative stress, all of which can contribute to insulin re-
sistance (166). Obese individuals are at particular risk of
OSA, and its prevalence has risen in recent years in the
United States, with estimates suggesting that 10% of
30–49 year-oldmen, 17%of 50–70 year-oldmen, 3%of
30–49 year-old women, and 9% of 50–70 year-old
women experienceOSA (167). Althoughobesity increases
the risk of OSA and is itself associated with insulin resis-
tance, insulin resistance in OSA has been shown to be
independent of adiposity (168). Furthermore, OSA is
highly prevalent in people with T2DM (169), and a meta-
analysis has shown that OSA is a strong risk factor for
T2DM development (170). Pregnancy also predisposes
women to OSA (171), and may worsen maternal glucose
metabolismandhence increase risk of gestational diabetes
(172). Continuous positive airway pressure is used to treat
OSA; whether it improves glucose metabolism is conten-
tious, but accumulating evidence suggests it may (173).
Wewould alsobe remiss to notmention that themetabolic
consequences of insomnia have not been thoroughly stud-
ied, despite it being the most common sleep disorder. As
sleep state misperception (the mistaken perception of
wakefulness during sleep) is common in insomnia, it will
be important to objectively measure sleep in these studies.
Although conflicting evidence exists (174), a meta-
analysis of sleep restriction studies showed that sleep re-
striction increases energy intakes in adults, contributing to
its obesogenic effects (175). This finding is consistentwith
an extended period in which food can be consumed to
compensate for the additional energetic cost of wakeful-
ness. Sleep restriction also increases energy intakes, and
the appeal and consumption of desserts among adoles-
Figure 2.
Mechanisms linking circadian system and sleep disruption to hyperglycemia, insulin resistance and obesity. With further research, mechanisms that
are currently listed as distinct may prove to be common.
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cents (176), and sleep deprivation has even been shown to
increase the energy content and mass of food purchased
per unit of money in a mock supermarket (177).
In the light of these findings, it might be expected that
sleep restriction influences satietyhormones, thebest stud-
ied of which are the satiety hormones ghrelin and leptin.
During ad libitum food availability, however, docu-
mented effects of sleep restriction on ghrelin and leptin are
contradictory (149, 178, 179). With that said, sleep re-
striction does appear to increase ghrelin concentrations
and hunger in adults consuming standardized hypoener-
getic diets (180), and ghrelin after sleep restriction is sub-
sequently positively correlatedwith energy intake at an ad
libitummeal (181). It is important to consider that a mul-
titude of hormones influence feeding behavior, and it was
recently shown that sleep restriction increases plasma con-
centrations of the orexigenic endocannabinoids 2-arachi-
donoylglycerol and 2-oleoylglycerol, perhaps also con-
tributing to increased energy intakes (182).
The energy expenditure side of energy balance may too
be affected by sleep restriction, as a working week sleep
restriction simulation study showed that sleep restriction
reduces restingmetabolic rate (RMR), particularly among
African Americans-a population highly susceptible to the
obesogenic effects of sleep restriction. Notably, this effect
was seen despite participants being in positive energy bal-
ances, which might be expected to have raised partici-
pants’ RMRs (183). Lean body mass is a key determinant
of RMR, and sleep restriction during hypoenergetic diet
consumption accelerates lean body mass losses and im-
pairs reductions in adiposity, providing a mechanism by
which chronic sleep disruption could detrimentally influ-
encebodycomposition (184).The importanceof adequate
sleep during energy restriction is supported by the finding
that longer sleep predicts greater reductions in BMI in
overweight and obese adults consuming hypoenergetic di-
ets (185).
Interestingly, within-participant effects of one night of
sleep restriction on energy intake and body mass changes
appear stable when repeated exposures are separated by
long periods of time, particularly among men, suggesting
trait-like responses to sleep disruption. Given large differ-
ences between individuals in changes in body mass (- 2.3
to6.5kg) and energy intakes (- 501 to1178kcal) after
one night of sleep restriction (186), and also that many
sleep variables are highly heritable (187), there is a need to
find biomarkers that identify thosemost vulnerable to ad-
verse metabolic effects. Some gene variants, like the
Y362H variant of basic helix-loop helix family member
e41, have been shown to confer carriers with resistance to
other effects of sleep deprivation, such as less need for
recovery sleep (188); perhaps biomarkers that influence
resistance to the metabolic sequelae of sleep disruption
will also be identified. Use of ‘omics’ technologies to study
sleep disruption is a particularly promising way of reveal-
ing mechanisms underlying this interindividual
variability.
‘Omics’ technologies in the study of circadian rhythm
and sleep disruption
Tremendous advances have been made in various ‘om-
ics’ techniques in recent years, including genomics, tran-
scriptomics, proteomics and metabolomics. Their high
throughput has particularly promising applications in
studying the circadian system and sleep, as exemplified by
the characterization of metabolites affected by sleep de-
privation by use of liquid chromatography/mass spec-
trometrymetabolomics, amethod that can also be applied
in field settings (189).
Studies applying metabolomics, proteomics and tran-
scriptomics continue to unveil new insights into sleep and
the circadian regulation of metabolism. Circadian system
regulation of physiology is reflected in the humanmetabo-
lome, 15%of which is clock-regulated. Under constant
routine conditions,  75% of oscillating blood plasma
metabolites are lipids, generally with acrophases around
lunchtime (190). A targeted lipdomics study has shown
that  13% of plasma lipids show 24 hour oscillations,
including lipids involved in energy storage, signaling and
transport. Interestingly, there is large heterogeneity
among healthy adults, and different lipid metabolic phe-
notypes have been identified (191). In saliva, amino acids
and associated metabolites comprise over half of oscillat-
ingmetabolites (190).While entrained to the LDcycle, the
proportion of rhythmic metabolites may be higher still,
with 64% of measured plasma metabolites found to have
24 hour rhythms, 87% of which peaked during the day
(189).
Omics techniques have also been applied to study cir-
cadian rhythm and sleep disruption. Sleep restriction pri-
marily modifies lipid, neurotransmitter, oxidative stress,
and gut metabolites (192), effects whichmay help explain
increased cardiometabolic disease risk in sleep-restricted
individuals (193). Similarly, sleep deprivation alters
rhythms in plasma metabolites including lipids and acyl-
carnitines, largely reducing the amplitude of metabolite
rhythms in comparison to when sleep is permitted (189).
Discoveries using transcriptomics corroborate many
metabolomics findings: One week of sleep restriction in
humans reduces the number of genes with 24 hour ex-
pression profiles by20% in the blood, influencing genes
involved in immunity, gene expression regulation, stress
responses, and metabolism (194). The extent of these
changes can be explained by the diversity of changes that
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occur during sleep, including changes in physical activity,
light exposure, redox state, and temperature, all of which
influence numerous physiological processes. Further-
more, complete (180°) circadian misalignment pro-
foundly affects the human blood transcriptome, produc-
ing a six-fold reduction in genes with 24 hour expression
profiles, an effect consistent with reduced core body tem-
perature rhythm amplitudes (195).
Use ofmultiomics techniques has the potential to reveal
novel insights into the systems-level regulation and inte-
gration of the circadian system and sleep homeostasis, in
addition to identifyingnovel biomarkers ofmetabolic dys-
function and circadian system and sleep disruption. On-
line repositories for omics datasets (for example,
Circadi0mics, http://circadiomics.igb.uci.edu/) could fa-
cilitate discoveries by integrating multiple omics ap-
proaches, and displaying temporal aspects of verified and
predicted network interactions between key metabolic
regulators, such as enzymes and transcription factors
(196).
There are conflicting findings regarding whether men
and women differ in their energy balance responses to
sleep disruption. A large study of 5 nights of sleep restric-
tion (4 hours of time in bed) found that men are predis-
posed to positive energy balances after sleep restriction
(197); however, a smaller, crossover study5nights of sleep
restriction (5 hours of time in bed) in amore homogeneous
group of younger adults indicated that women are more
susceptible (198). Further research is required to under-
stand these discrepant findings. Certainly, sex does influ-
ence certain responses to sleep restriction, as seen in men-
strual cycle phase dependent endocrine responses to sleep
restriction (199), and there is a general need to clarify how
the menstrual cycle influences responses to circadian
rhythm and sleep disruption.
Finally, it is likely that changes in sleep architecture
during sleep disruption influence eating behavior: The fi-
nal REM period, for example, is hypothesized to be pro-
tective against overeating (200). Experiments should con-
tinue to assess associations between sleep architecture,
behavior and physiology.
2. Effects on dietary choices
It has been estimated that US adults make 230 food-
related decisions daily (201). If sleep disruption adversely
influences dietary choices, its deleteriousmetabolic effects
could be compounded. Although sleep restriction has
sometimes been found to influence dietary macronutrient
proportions, conflicting evidence exists (197). Notably,
macronutrient intakesdependonavailable foods, and lim-
ited snack options are available in experimental settings.
Rather than altering macronutrient preferences, recent
brain imaging studies support the hypothesis that sleep
disruption increases nonhomeostatic eating propensity.
Sleep restriction accentuates increased activity in brain
regions involved in reward in response to food stimuli
(202), suggesting heightened sensitivity to rewarding
properties of food. Brain activity changes after sleep de-
privation are consistentwith increased appetite (203), and
activity in one of these regions, the nucleus accumbens, is
particularly highly associated with energy-dense food se-
lection (204). Furthermore, sleep restriction strongly in-
fluences insula activation in response to images of food
perceived as ‘unhealthy’, a region involved in pleasure-
seeking, even following a day in which sleep-restricted
participants consumed more energy than control partici-
pants (205).
Finally, accurate recollection of food consumption in-
fluences short term food ingestion, an extreme example of
which is seen in amnesiacs who will eat multiple meals
consecutively (206). Hippocampal changes following
sleep deprivation contribute to memory impairments
(207), and hippocampal activity helps prevent meal initi-
ation in the postprandial period (208).While it is plausible
that sleep disruption may increase food intake by influ-
encing hippocampal activity, this hypothesis requires fur-
ther testing.
Collectively, these studies suggest that experimental
sleep restriction and deprivation induce a plethora of ad-
verse metabolic consequences that may be accentuated by
changes in food selection. Experimental sleepdisruption is
often more severe than that experienced outside the lab-
oratory; therefore, studies of less marked sleep restriction
and further field studies are needed.
B. Limited daytime light exposure
People in industrialized societies typically spend 
88% of their time in enclosed buildings, sheltered from
natural light (209). Time spent outdoors inCanada,Great
Britain and the United States is commonly one to three
hours daily (210–212), depending on season and other
factors and, compared to exposure to only natural light,
individuals in modern societies are perhaps exposed to
about four times less light during the day (213). Conse-
quently, many individuals, particularly urban popula-
tions, are sheltered from the diverse beneficial effects of
natural daytime light on behavior and physiology (214).
Vitamin D is synthesized in response to ultraviolet
(UV)-B irradiation, and indoor living in industrialized ar-
eas is one contributor to low vitamin D status. Although
consistent evidence linking vitamin D status to morbidity
is contentious, associations with some health parameters
exist (215). It is well established that the LD cycle is the
primary zeitgeber for humans; however, as vitamin D di-
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rectly influences clock gene transcription in vitro (216), it
is possible that some of the associations between vitamin
D status and health may arise from effects of vitamin D
status on circadian rhythms and sleep. Negative associa-
tions between vitamin D status and sleep duration (217–
219) and sleep efficiency (217, 219) corroborate this con-
tention; nevertheless, this may simply reflect beneficial
effects of greater daytime light exposure on sleep rather
than effects of vitamin D on the molecular clock.
C. Increased light exposure at night
Although outdoor light levels do not always reflect ret-
inal light exposure, about 75% of the world’s population
is exposed to artificial light at night (220), and it has been
estimated that individuals in modern societies commonly
experience light intensity levels over twice as high between
sunset and sleep compared to exposure to only natural
light (213). This appears to significantly influence sleep:
The introduction of electric lighting is associated with in-
creased light exposure shortly after dusk during work-
days, delayed sleep onset and shortened sleep duration
among individuals of the same sociocultural background.
These effects may be particularly prominent duringwork-
days (221, 222). Although the authors of a recent study of
three hunter-gatherer communities livingwithout electric-
ity suggested that individuals living without artificial
lighting may not sleep for longer than individuals with
lighting (223), this suggestion was not supported by a
comparison between the hunter-gatherer groups and in-
dividuals of similar ethnic origins with access to artificial
lighting (224).
In addition to artificial lights, many electronic devices
increase night-time light exposure. Given their compact-
ness, it might be expected that any effects of these devices
on the circadian system and sleep would be benign. How-
ever, some of these devices emitmonochromatic blue light
(max 460–480 nm), to which intrinsically photosensitive
retinal ganglion cells are especially sensitive. Indeed, irra-
diance levels as low as 2 W cm-2 of such light suppress
nocturnal melatonin production (225, 226). As a result,
exposure to even low levels of light at night from e-Book
devices delays sleep and dim-light melatonin onset, re-
duces melatonin synthesis, and impairs next-morning
alertness. As about 90% of Americans use electronic de-
vices within an hour of bed time on multiple nights each
week, these devices are likely further contributing to cir-
cadian rhythm and sleep disruption (227).
There are positive associations between night-time il-
lumination and obesity prevalence in  80 countries
worldwide (228), and also between mean timing of light
exposure above 500 lux and BMI in free-living adults
(229). Given the aforementioned discussion of the sleep-
disrupting effects of light exposure, as well as the multi-
tude of factors that conspire to increase energy balance
after sleep disruption, it seems likely that increased light
exposure at night is another contributor to the obesity
epidemic.
D. Shift work
Even when diet is controlled, night shift workers ex-
hibit poorer metabolic health than day workers. Night
workers, for example, have higher plasma triacylglycerol
(230), and field work has shown that this is related to
circadian system disruption, as postprandial glucose and
lipid tolerance to standard test meals are impaired on
switching to night shifts (231). Likemetabolic health, cog-
nitive function is frequently impaired by night shift work.
Transitioning from day to night shifts often entails sleep
deprivation, andperformancedecrements during this time
can be comparable to blood alcohol levels that exceed the
legal driving limit (232).
An important determinant of shift work tolerance is
entrainment to shift schedules. Isolated environments can
be more conducive to adaptation to shift work than more
common shift working scenarios, and in circumstances
such as workers on the British Antarctic base at Halley or
on oil rigs, most workers can synchronize their circadian
systems to night shifts within a week (233). Even in these
instances, however, it can take weeks for workers to re-
entrain to day shifts (234–236).
Workers who exclusively work night shifts might be
expected to completely entrain their circadian systems to
their work hours (6). However, disrupted endocrine cir-
cadian rhythms persist even among adults who have
workednight shifts forover twoyears.These chronicnight
shift workers have altered thyroid stimulating hormone
profiles, and reduced cortisol secretion and increased pro-
lactin secretion during theirwaking hoursmay impair vig-
ilance (237).
Laboratory experiments have attempted to simulate
shift work to clarify its metabolic consequences. As dis-
cussed previously, it is apparent that sleep restriction re-
duces insulin sensitivity; however, circadianmisalignment
imposed by LD cycle shifts nearly doubles reductions in
insulin sensitivity after sleep restriction alone in males,
also furthering inflammation (238). Some shift work sim-
ulation experiments have produced conflicting findings
regarding several metabolic variables. During six days of
simulated night shift work in healthy adults, there was an
initial increase in fat oxidation, and reductions in carbo-
hydrate and protein oxidation. Diet-induced thermogen-
esis temporarily fell, and energy expenditure declined on
the second and third days, particularly during sleep. Par-
adoxically, appetite diminished despite reduced levels of
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the orexigenic hormones leptin and peptide tyrosine ty-
rosine (239). However, in contrast to these findings, nei-
ther three consecutive three hour LD cycle advances nor
three consecutive three hour LD cycle delays influenced
appetite or energy expenditure in adults, and both shifts
increased carbohydrateoxidationand reducedproteinox-
idation. In this study, LD cycle advances acutely reduced
cortisol rhythm amplitudes and increased insulinemia,
whereas LD cycle delays increased glycemia, and de-
creased glucagon-like peptide-1 concentrations and sleep-
ing energy expenditure (240). Discrepancies between
some of these findings likely reflect differences in experi-
mental design, emphasizing the need to compare a variety
of shift schedules when attempting to offset deleterious
consequences of shift work.
Other circadianmisalignment protocols have provided
new insights into the short-term health consequences of
shift work. Circadian misalignment increases BP (partic-
ularly during sleep) and inflammatory markers, reverses
cortisol rhythms, and reduces heart rate variability and
insulin sensitivity in healthy adults (128, 241). Further-
more, misalignment increases postprandial glycemia de-
spite enhanced late-phase insulin secretion (242). Pro-
longed circadian misalignment reduces cortisol secretion
(243), and, while acute circadian misalignment increases
insulin secretion (128), three weeks of combined sleep re-
striction and circadian misalignment impairs insulin se-
cretion, indicating pancreatic dysfunction (244). An im-
portant question is whether chronic exposure to circadian
rhythm and sleep disruption produces adaptations that
mitigate the adverse effects of subsequent disruptions to
the endocrine system. It appears that this may not be the
case, however, as healthy chronic shift workers are still
subject to the deleterious effects of circadianmisalignment
on postprandial glucose tolerance and insulin action
(245).
Collectively, these studies indicate possible mecha-
nisms linking shift work to increased metabolic disease
risk and show a need to optimize shift work schedules
(direction, duration and frequency) to minimize deleteri-
ous health effects. In general, changing from backward to
forward shift rotation, shifting from slow to fast shift ro-
tation, and allowing self-scheduling of shifts appear to
benefit the health and quality of life (QOL) of shift work-
ers (246). Superficially minor details can profoundly in-
fluence adaptation to shift work, as demonstrated by de-
layed circadian phase ( 3 hours) and shortened sleep (
1hour) in offshoreworkerswhose night shiftswere just an
hour later (247). As individual tolerance to shift work
varies widely (248), it will be important to find ways of
determining those at highest risk of shift work-induced
circadian rhythm and sleep disruption. There is a need to
further study how to optimize shift work schedules based
on chronotype (249) as observational evidence suggests
that associationsbetween shiftwork schedules andT2DM
are related to chronotype (250), and experimentally ma-
nipulating shift work schedules based on chronotype can
reduce circadian rhythm and sleep disruption (251). No-
tably, as shift work and jetlag are both initially charac-
terized by attempts to abruptly change sleep/wake cycle
timing, many of metabolic aberrations seen in acute shift
workmaybe applicable to individuals experiencing jetlag.
IV. Circadian system genetics and metabolism
As the circadian system is intertwined with metabolic
regulation, recent studies have focused on deciphering
whether circadian systemgene single-nucleotide polymor-
phisms (SNPs) are associated with metabolic health in
adults. Studies of clock gene disruption in other animals
paved theway for these studies, as whole-body and tissue-
specific clock gene mutation and knockout models pro-
duce various feeding andmetabolic aberrations in rodents
(252, 253). Perhaps the most severe example of this is the
abolition of all measured behavioral and molecular circa-
dian rhythms in mice following Bmal1 knockout. These
animals also succumb to premature mortality (254).
In rare cases, genetic abnormalities produce develop-
mental disorders which entail circadian system disorga-
nizationandmetabolic dysfunction.Retinoic acid induced
1 (RAI1) transcriptionally regulates CLOCK, and haplo-
insufficiency of RAI1 is the primary contributor to the
Smith–Magenis syndrome phenotype, a disorder charac-
terized by circadian rhythm and sleep disruption, intellec-
tual disability and obesity (255).
GWAstudies provide the strongest evidence for roles of
more common circadian system gene variants in human
metabolism and disease risk. GWA studies have linked
PER3 to T2DM (256) and CRY2 with fasting glycemia
and insulin concentrations (257). In these studies, mela-
tonin receptor 1B (MTNR1B) variants are also consis-
tently associated with insulin secretion and T2DM risk
(142–144).
Less robust evidence for ties between circadian system
gene variants andmetabolism comes from candidate gene
studies. In adults, two BMAL1 haplotypes have been
linked to hypertension and T2DM (258, 259). CLOCK
SNPs have been associated with nonalcoholic steatohepa-
titis, metabolic syndrome, small dense low-density lipo-
protein (LDL) levels, obesity, and T2DM (260–264). Per-
haps the most studied of these associations is that of
obesity; to date, eight common SNPs have been linked to
obesity and three have been associatedwith energy intakes
(265).
An ultimate goal of candidate gene studies is to help
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personalize healthcare. A recent meta-analysis of up to
28 190participants from15cohort studies sought to iden-
tify whether nutrition and sleep modify associations be-
tween select circadian system gene variants and cardio-
metabolic traits. Carbohydrate intake was positively
associated with fasting glycemia in the presence of the T
allele ofMTNR1B rs1387153 (266). Moreover, long (
9 hours) sleep was associated with increased BMI in the
presence of this allele. Finally, sleep duration was posi-
tively associatedwith high-density lipoprotein cholesterol
(HDL-C) among carriers of the A allele of CRY2-
rs11605924. CLOCK, CRY and REV-ERB variants
were not found to interact with nutrition to influence car-
diometabolic health, however.
Collectively, SNP studies suggest that knowledge of cir-
cadian gene SNPs may eventually help identify those at
greatest risk of some diseases and personalize interven-
tions.However, candidate gene studies are limited by their
sample sizes, their exclusionofall causativegenesandgene
variants, and their limited replicability. Hence, such stud-
ies need replicating in larger, unbiased GWA studies.
V. Countermeasures against the metabolic consequences
of circadian rhythm and sleep disruption
Several interventions have promise in mitigating the
metabolic consequencesof circadian rhythmand sleepdis-
ruption (Figure 2). It is important to note that circadian
rhythm and sleep disruption can have distinct effects, and
sleep timing per se has but small effects on circadian sys-
tem phase (267); it is perhaps changes in light exposure
during sleep because of the closing of the eyes that is likely
to have the most strong effect on the circadian system.
Nevertheless, the homeostatic regulation of sleep is inter-
twined with the circadian pacemaker in the SCN, so strat-
egies to counter each should consider this interaction, and
interventions should be tailored to individual
circumstances.
In the case of sleep restriction, sleep extension appears
to benefitmany aspects ofmetabolic health.Among short-
sleeping adults, increased time in bed after a sleep exten-
sion intervention is associated with improvements in glu-
cose regulation and insulin sensitivity (268), andas little as
three days of sleep extension may benefit insulin metab-
olism and increase testosterone in habitually short-sleep-
ingmen. Interestingly, sleepextension reduced theanorex-
igenic peptide hormones leptin and peptide tyrosine
tyrosine, although effects on food intakewere not assessed
(269). Although the need to nap during the daytime may
reflect less robust sleep/wake rhythms and hence be asso-
ciated with adverse health effects including excessive in-
flammation (270), use of morning and afternoon napping
after sleep restriction reduces increased afternoon urinary
norepinephrine excretion towardsnormal values, andalso
returns salivary interleukin-6 levels towards baseline from
suppression (271).
Sleep extension may also improve body composition.
Indeed, increased sleep duration is prospectively associ-
ated with attenuated increases in adiposity in short-sleep-
ers (272), and findings from a study of overweight, habit-
ually short-sleeping young adults suggest that this may be
related to increased energy expenditure. Among these in-
dividuals, two weeks of two hours’ increased time in bed
in home environments increased sleep duration and day-
time energy expenditure, and reduced appetite and desire
for highly palatable foods (273). One factor that may in-
fluence the effects of sleep extension interventions on di-
etary habits is chronotype. Using a crossover design to
change the time at which adolescents went to bed and
thereby compare a 6.5 to a 10 hour sleep opportunity for
five nights, longer sleep opportunity reduced evening eat-
ing among individuals with earlier chronotypes only, de-
spite similar sleep timing and duration between chrono-
types (274). Hence there is a need to further study the
influence of chronotype on appropriate bed time recom-
mendations. Finally, sleep extensionmay benefit other be-
haviors. A systematic review of naturalistic studies re-
cently found that delaying school start times increases
students’ sleep durations, and therewas some evidence for
concomitant improvements in behavior and affect (275).
Improvements in sleep hygiene are a natural starting point
in attempts to better sleep, and further research on opti-
mizing such variables as sound, bedding, mattresses, and
temperature may benefit sleep.
Pharmaceutical chronobiotics have potential in coun-
tering circadian rhythm disruption. For example, phar-
maceutical inhibition of CK1 helps synchronize mis-
aligned oscillators and hence speeds adaptation to LD
cycle shifts in mice (276, 277), as can therapeutic SCN
neuropeptidemodulation (278). Furthermore, an array of
clock-enhancing small molecules may ultimately provide
effective therapies for disorders of the circadian system
(279). Intriguingly, a circadian clock was recently trans-
planted into a noncircadian organism for the first time,
and such methods could have chronotherapeutic applica-
tions, such as regulation of timely drug release (280). This
is particularly pertinent given that most of the highest-
selling drugs target the products of rhythmically tran-
scribed genes (78).Of note, pharmaceutical chronobiotics
may also benefit metabolic health. REV-ERB agonists, for
example, diminish adiposity, hyperglycemia and hyper-
lipidemia in diet-induced obese mice (281). However,
none of these compounds has yet been tested for safety or
efficacy in humans.
Other well-established therapies like melatonin (282)
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should be further studied for effects on food selection and
metabolism in humans. Interestingly, one year of melato-
nin supplementation was recently shown to increase lean
bodymass and reduce fatmass in postmenopausalwomen
with osteopenia (283), and daily ingestion of prolonged-
release melatonin reduced glycosylated hemoglobin in in-
dividuals with insomnia and T2DM (284). Finally, caf-
feine, the most commonly consumed psychoactive
substance worldwide, changes the period of both the mo-
lecular clock invitro and themelatonin rhythm inhumans,
and timely caffeine ingestion may therefore help entrain-
ment in such circumstances as jetlag (285, 286).
Nonpharmaceutical interventions are also capable of
improving circadian system function and sleep, including
blue-blocking glasses and apps to filter short-wavelength
emissions from electronic devices (287, 288). As the
brightness, color, duration, and timing of light exposure
influence many physiological functions (289–291), it is
feasible that these interventions could influence the phase
of the SCN and numerous other processes independent of
the SCN, including activity in other brain regions and en-
docrine networks that help regulate appetite. By enabling
consumers to have greater control of their light environ-
ments, developments in ‘smart’ light technology may be
particularly important to improving circadian system
alignment and optimizing changes in sleep pressure to co-
incide with times appropriate for individual chronotypes.
In a similar vein, consideration should be given to light
exposure when designing buildings and their windows.
The timing, composition and quantities of foods in-
gested influence the circadian system (292), as exemplified
by the restoration of behavioral and physiological
rhythms in SCN-ablated rats by a single, timed hypoen-
ergetic daily meal (293). Time-of-day-restricted feeding
(TRF) limits feeding to a period of several hours and
thereby produces clear feeding/fasting cycles. As the mo-
lecular clock is intertwined with the metabolic state of the
cellular environment, TRF to the rest phase can invert
clock gene rhythms in many peripheral tissues (294).
When TRF is imposed with ad libitum food availability in
mice, SCN gene expression rhythms are similar to those
without TRF, and TRF can therefore change the phase
relationships between gene expression rhythms in periph-
eral tissues and the SCN. Hypoenergetic diets, however,
can phase shift peripheral tissue gene expression profiles
and also have a small influence on SCN gene expression
rhythms (295). Whether similar effects of TRF schedules
are evident in humans is currently unclear; if evident, TRF
may too be a useful strategy in situations where resyn-
chronization with the external environment is desired.
TRF produces an array of metabolic health benefits in
various animals (296), but little research has explored
whether this is true of humans. It is apparent, however,
that many of us eat in a very erratic manner, and a pilot
study of 8 overweight adults found that reducing habitual
feeding period from  14 hours to 10–11 hours reduced
energy intake and body mass, and improved perceptions
of sleep (297). Furthermore, there is some evidence that
the timingof food intakemay influence the effectiveness of
weight loss interventions, as greater energy intake earlier
in the day has been associated with greater weight loss in
prospective studies of overweight and obese adults (298,
299).
Finally, reciprocity between physical activity and the
circadian system exists, as both experimental circadian
rhythm disruption and diseases associated with SCN dys-
function disrupt physical activity patterns (300, 301), and
physical activity influences melatonin rhythms a little, as
well as peripheral tissue gene expression rhythms (302,
303). Furthermore, the circadian system regulates auto-
nomic control of cardiovascular responses to exercise, re-
sulting in peak cardiac vagal tonewithdrawal in themorn-
ing, and a bimodal acrophase in epinephrine and
norepinephrine reactivity to exercise in both the morning
and evening, perhaps helping explain the increased risk of
cardiovascular events at these times (304). The extent to
which the beneficial metabolic effects of exercise are me-
diated by the circadian system is unclear; regardless, the
health-promoting effects of exercise are extensive. Most
human circadian rhythm and sleep disruption experi-
ments to date have enforced minimal physical activity.
Rodent studies suggest that physical activity offsets some
adverse metabolic effects of light exposure at night (305).
Exercise may also offset some of the deleterious effects of
sleep disruption, as resistance training attenuates the cat-
abolic effects of sleep deprivation on lean body mass in
rats, perhapsbyoffsetting changes in testosterone, insulin-
like growth factor-1 and corticosterone (306). As there is
a paucity of human studies on the subject, it will be im-
portant to study how to optimize exercise protocols to
mitigate metabolic dysfunction induced by circadian
rhythm and sleep disruption.
VI. Conclusions
In modern societies, circadian rhythm and sleep dis-
ruption are perhaps more pervasive than ever. There is
increasing evidence of detrimental effects on metabolic
function and dietary choices, emphasizing the importance
of bolstering circadian system function and addressing
sleep disruption. As an appreciation of the importance of
circadian system entrainment and sleep may significantly
enhance health and productivity formany individuals, ed-
ucating key personnel has great potential to benefit
society.
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The circadian system optimizes behavior and physiol-
ogy according to the time of day and is organized in a
hierarchical manner, with a central clock in the SCN that
is primarily entrained by light. Nowadays we are com-
monly exposed to less light during the day and more light
at night because of artificial lighting, which may impair
circadian system organization and disrupt sleep, resulting
in widespread adverse effects on metabolic health. Dis-
rupted sleep, for example, promotes increased energy in-
take, reduced energy expenditure and insulin resistance in
many individuals, consequences which may be com-
pounded by an increased propensity to make less healthy
dietary choices. Careful experiments have also shown that
circadian misalignment produces an array of metabolic
abnormalities.
Future research should continue to study factors influ-
encing individual variation in the risk of and responses to
circadian rhythm and sleep disruption, such as sex differ-
ences in circadian rhythms (307), associations between
ethnicity and sleep variability (308), and other factors that
contribute to differences in metabolic and behavioral re-
sponses to circadian rhythm and sleep disruption between
individuals. It may not always be possible to extrapolate
findings from animal studies to humans (309), indicating
a need for continued human research, especially in pop-
ulations experiencing frequent circadian rhythmand sleep
disruption. Furthermore, little research has explored such
disruption in diseases like T2DM. There has also been
little research on large populations likely experiencing cir-
cadian rhythm and sleep disruption. People living in
China, for example, may be of particular interest, as the
country spans five geographical time zones, yet the entire
nation follows Beijing time. It is plausible that chronic
circadian rhythm and sleep disruption may incur some
adaptations in the affected, although little research has
addressed this to date.
Finally, behavioral and pharmaceutical interventions
show promise in offsetting the adverse effects of circadian
rhythmand sleep disruption. Someof the beneficial effects
of these interventionsmay be independent of the circadian
system and sleep, however. As our understanding of the
range of healthy phase relationships between the SCNand
peripheral clock systems is poorly characterized, clarify-
ing these relationships could help personalize prescription
of chronobiotics, some ofwhich still require human safety
and efficacy studies. Thereafter, comparisons of these in-
terventions areneeded to evaluatewhicharemost effective
and in what circumstances.
Ultimately, we hope that mankind’s historic fascina-
tion with the temporal world will continue to draw inter-
est to the importance of the human timing system in all
facets of health.
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